Cite
MLA Citation
D.F.L. Liew et al.. “THU0616 Elevated thyroid stimulating hormone as a potential biomarker for rheumatic immune-related adverse events following pd-1 inhibitor therapy.” Annals of the rheumatic diseases, vol. 77, n.d., p. 506. http://access.bl.uk/ark:/81055/vdc_100144715616.0x000047